文献速递功能神经外科神经肿瘤

扣带回癫痫手术疗效:基于本机构病例与患者水平系统综述及荟萃分析的见解

Outcomes of cingulate epilepsy surgery: insights from an institutional and patient-level systematic review and meta-analysis.
PubMed 文献 · J Neurosurg · 2021-11-19

本研究通过系统检索文献并补充本机构4例病例,纳入21项研究共105例扣带回癫痫患者,评估手术后结局。末次随访(至少12个月)无癫痫发作率为72%,暂时性神经功能缺损24%,永久性缺损3%,病灶性癫痫患者无发作概率显著更高(p=0.015)。作者认为对精心选择的患者,手术安全且长期无发作率高。

要点

  • 105例扣带回癫痫患者术后末次随访无癫痫发作率为72%(中位随访24个月)。
  • 术后神经功能缺损发生率27%,其中暂时性24%,最常见为运动无力13%和辅助运动区综合征9.5%。
  • 病灶性癫痫患者无发作概率显著高于非病灶性(p=0.015,log-rank检验)。

核心结论

  • 对药物难治性扣带回起源局灶性癫痫,手术治疗安全,永久性不良影响发生率低,在精心选择的患者中可获得高长期无发作率。
  • 这些数据可作为扣带回癫痫患者手术咨询的基准。

研究设计与样本

  • 系统检索PubMed/MEDLINE、Ovid Embase、Ovid Scopus和Cochrane Library数据库,纳入探究扣带回癫痫患者术后结局的研究,并补充作者本机构系列(4例患者)。
  • 共纳入21项研究,合计105例患者(病灶性癫痫68例,占65%)。

主要发现

  • 手术时中位年龄23岁,男性占56%,中位癫痫病程7.5年。
  • 69%患者行侵入性脑电图记录(病灶性癫痫53% vs 非病灶性癫痫97%,p<0.001)。
  • 最常见切除区域为前扣带回(55%),其次为后扣带回(17%)和中扣带回(14%);仅行病灶切除术者占9%。
  • 54%患者接受额外扣带回外治疗(病灶性癫痫53% vs 非病灶性癫痫57%,p=0.87)。
  • 最常见病理为皮质发育不良(54%),其次为低级别肿瘤(29%)和胶质增生(8%);末次随访无癫痫发作率72%(中位随访24个月)。

临床怎么用

  • 作者认为手术治疗对药物难治性扣带回起源局灶性癫痫安全,永久性不良影响发生率低,在精心选择的患者中可获得高长期无发作率。
  • 作者认为这些数据可作为扣带回癫痫患者手术咨询的基准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Due to their deep and medial location, range of seizure semiologies, and poor localization on ictal electroencephalography (EEG), cingulate gyrus seizures can be difficult to diagnose and treat. The aim of this study was to review the available evidence on postoperative outcomes after cingulate epilepsy surgery. METHODS: A comprehensive literature search of the PubMed/MEDLINE, Ovid Embase, Ovid Scopus, and Cochrane Library databases was conducted to identify studies that investigated postoperative outcomes of patients with cingulate epilepsy. Seizure freedom at the last follow-up (at least 12 months) was the primary endpoint. The literature search was supplemented by the authors' institutional series (4 patients). RESULTS: Twenty-one studies were identified, yielding a total of 105 patients (68 with lesional epilepsy [65%]). Median age at surgery was 23 years, and 56% of patients were male. Median epilepsy duration was 7.5 years. Invasive EEG recording was performed on 69% of patients (53% of patients with lesional epilepsy and 97% of those with nonlesional epilepsy, p < 0.001). The most commonly resected region was the anterior cingulate (55%), followed by the posterior (17%) and middle (14%) cingulate. Lesionectomy alone was performed in 9% of patients. Additional extracingulate treatment was performed in 54% of patients (53% of patients with lesional epilepsy vs 57% of those with nonlesional epilepsy, p = 0.87). The most common pathology was cortical dysplasia (54%), followed by low-grade neoplasm (29%) and gliosis (8%). Seizure freedom was noted in 72% of patients (median follow-up 24 months). A neurological deficit was noted in 27% of patients (24% had temporary deficit), with the most common deficit being motor weakness (13%) followed by supplementary motor area syndrome (9.5%). Univariate survival analysis revealed significantly greater probability of seizure freedom in patients with lesional epilepsy (p = 0.015, log-rank test). CONCLUSIONS: Surgical treatment of drug-resistant focal epilepsy originating from the cingulate gyrus is safe, leads to low rates of permanent adverse effects, and leads to high rates of long-term seizure freedom in carefully selected patients. These data may serve as a benchmark for surgical counseling of patients with cingulate epilepsy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kerezoudis P, Singh R, Worrell GA, et al. Outcomes of cingulate epilepsy surgery: insights from an institutional and patient-level systematic review and meta-analysis. J Neurosurg. 2021. PMID: 34798605. doi:10.3171/2021.8.JNS211558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。